Virus in Medical Technology

Schering-Plough Expands Vicriviroc Phase II Study in Treatment-Naive Patients With HIV

... HIV-infected patients with R5-type virus only. In this study, vicriviroc is being ... is an HIV entry inhibitor designed to prevent the virus from infecting healthy CD4 cells by blocking its ... 80-90 percent of treatment-naive patients have virus that uses the CCR5 co-receptor.(1) ...

Landmark Study for GSK's Cervical Cancer Vaccine Published in The Lancet

... 33 and 45, the three most common cancer-causing virus types beyond 16 and 18. Thomas Breuer, Head ... with the five most common cancer-causing virus types. This is really good news for primary ... against the most common cervical cancer-causing virus types and has the potential to substantially ...

Hand Washing with 4% CHG Antiseptic Kills Flu Viruses

... that Hibiclens(R), a 4% CHG product, reduced the virus by 99.94 percent after 30 second, 60 second, and ... 70% isopropyl alcohol formulation, reduced the virus by 99.99 percent after 15 second, 30 second and ... of influenza outbreak, managing the spread of virus is the biggest concern," said Carolyn Twomey, RN, ...

Jennerex Therapeutic Research Collaboration With Ottawa Hospital Research Institute Selected for $10 Million Grant From Ontario Institute for Cancer Research

... pleased that Dr. Bell and Jennerex's oncolytic virus technologies have been given this vote of ... class investigators at OHRI. Jennerex oncolytic virus products are being manufactured in the "Mulcahy ... first GMP facility dedicated to oncolytic virus production. Some of these development costs will ...

New Analysis Shows Efficacy of SIMPONI(TM) (golimumab) in Anti-TNF Experienced Rheumatoid Arthritis Patients

... a vaccine. Reactivation of hepatitis B virus has been reported in patients who are carriers of this virus and are taking TNF blocker medicines, such as ... know or think you may be a carrier of hepatitis B virus or if you experience signs of hepatitis B ...

Two-Year Data Show Patients Receiving SIMPONI(TM) (golimumab) Experienced Sustained Improvement in Signs and Symptoms of Psoriatic Arthritis and Ankylosing Spondylitis

... a vaccine. Reactivation of hepatitis B virus has been reported in patients who are carriers of this virus and are taking TNF blocker medicines, such as ... know or think you may be a carrier of hepatitis B virus or if you experience signs of hepatitis B ...

Aethlon Medical to Present at the 2009 RedChip Small-Cap Investor Conference on June 16, 2009

... to inhibit disease progression of Hepatitis-C virus (HCV) and Human Immunodeficiency virus (HIV), and serves as a broad-spectrum treatment ... (Bird Flu), the reconstructed 1918 influenza virus (r1918), West ...

Swine Flu (H1N1) Infectivity to Increase Markedly and Lethality to Remain Low According to Latest Replikin* Peptide Genomic Data

... and determined that the infectivity of the H1N1 virus will increase markedly, while its lethality will ... destroy or restrict replication of the targeted virus strains prior to an outbreak." Earlier this ... It has not previously been possible to correlate virus structures with ...

Novel Vaccine Approach Offers Hope in Fight Against HIV

... scientists protected monkeys from infection by a virus closely related to HIV -- the simian ... or killer cells that would eliminate the virus before or after it infected cells in the body. ... immunoadhesins was engineered into a carrier virus designed to deliver the DNA to monkeys. The ...

Quest Diagnostics Introduces First Commercial Laboratory Test for Identifying the H1N1 Swine Flu Virus

... positive for Influenza A H1N1 Swine-origin flu virus MADISON, N.J., May 11 ... Influenza A H1N1 Swine-origin (H1N1) flu virus ("S-OIV" or "novel H1N1"), also known as the ... of patients infected with the novel H1N1 virus and differentiate patients infected with other ...

Corgenix, Tulane Announce Award of NIH Grant Extending Hemorrhagic Fever Virus Product Development Program

... is the second grant awarded to Tulane for Lassa virus products. Under the original grant awarded in ... and patented new recombinant proteins for Lassa virus and developed several viral detection products ... tests typically require the culture of live Lassa virus in a high-containment laboratory to produce ...

Smithfield Sends Update to Employees on Testing Process at Veracruz Joint Venture

... the World Health Organization has renamed this virus A(H1N1). In addition, the CDC and all other ... Obama and others, that the A(H1N1) influenza virus is not transmitted by food and can only pass from ... will not have any effect on the food chain. This virus spreads the same way that the seasonal flu does ...

Arrayit to Mass Produce Rapid H1N1 Swine Flu Test Chip

... and clinicians to detect the presence of the virus in infected patients and livestock and to ... poses a pandemic risk because the H1N1 flu virus contains genetic elements from both the swine and ... around the world are concerned that the influenza virus could one day mutate and acquire the properties ...

Doctors Urge Precaution to Shield Against Swine Flu

... 2006. Compared with animals exposed to the H1N1 virus without consuming AHCC, the viral load in the ... infection while helping to clear the influenza virus rapidly from the lung. "You've got to be ... are going to be very important in fighting this virus especially prior to and within the first couple ...

Schering-Plough Highlights Hepatitis C Clinical Data Presentations at the European Association for the Study of the Liver (EASL) Annual Meeting

... care worldwide for treating chronic hepatitis C virus (HCV) infection. Patients with HCV genotype 1, ... response to therapy, defined as having detectable virus (HCV RNA) with at least a 2 log10 reduction in viral load at treatment week 12 and undetectable virus at treatment week 24. In this large, ...

Ground-Breaking Combination of All-Oral Agents Demonstrates Potential as Hepatitis C Treatment Regimen

... chronically infected with the hepatitis C virus (HCV)(1). The study combined two oral DAAs, ... groups were below the limit of detection of the virus in their blood (less than 15 IU/mL) after 14 ... the treatment of adults with chronic hepatitis C virus infection who have compensated liver disease and ...

Roche and Pharmasset Initiate Phase IIb Clinical Trial of R7128, Most Advanced Nucleoside Polymerase Inhibitor in Development for Chronic Hepatitis C

... About Hepatitis C The hepatitis C virus (HCV) is transmitted primarily through blood or ... therapeutics for the treatment of hepatitis C virus (HCV) and human immunodeficiency virus (HIV). Pharmasset is currently developing three ...

Data Presented at AACR Annual Meeting Show Anti-Tumor Activity of Peregrine's Fully Human Anti-PS Antibody in Prostate Cancer Model

... for the treatment of cancer and serious virus infections, today announced that preclinical data ... trials for the treatment of cancer and serious virus infections. The company is pursuing three separate clinical programs in cancer and hepatitis C virus infection with its lead product candidates ...

Pharmasset Voluntarily Halts Clinical Studies with Clevudine in Hepatitis B Infected Patients

... to infection with e-antigen positive hepatitis B virus (QUASH 305) or e-antigen positive (QUASH 306) who ... the effect of clevudine on reducing levels of virus in the blood and normalization of liver function ... therapeutics for the treatment of hepatitis C virus (HCV) and human ...

Pharmasset Initiates First Time in Human Study of PSI-7851 for the Treatment of Hepatitis C (HCV)

... analog polymerase inhibitor of hepatitis C virus (HCV). Pharmasset filed an Investigational New ... therapeutics for the treatment of hepatitis B virus (HBV), hepatitis C virus (HCV) and human ...

FDA Approves an Expanded Indication for Peginterferon-Based Combination Therapy for Patients With Chronic Hepatitis C

... failed prior treatment of their hepatitis C virus (HCV) infection, representing a large and growing ... the approval, achievement of undetectable virus (HCV-RNA) at treatment week 12 was a strong predictor of SVR. Patients who still had detectable virus at week 12 of therapy were highly unlikely to ...

GeoVax Starts Injections for Phase 2a Human HIV/AIDS Vaccine Trial in USA

... Ab response against the natural form of the virus envelope glycoprotein as well as protective T ... Therapeutic trials of a simian immunodeficiency virus (SIV) prototype of the GeoVax HIV vaccine in SIV ... Immunodeficiency Disease (AIDS), caused by the virus known as HIV-1, should the person ever become ...

Abbott and Enanta Initiate Phase 1 Clinical Trial on ABT-450 HCV Protease Inhibitor

... healthy volunteers. About the Hepatitis C virus Hepatitis C is a liver disease affecting more than 170 million people worldwide. The virus is spread through direct contact with the blood ... increase the proportion of patients in whom the virus can be eradicated. About Enanta ...

Franco Nuschese Tapped by Robert C. Gallo Foundation for AIDS and Virus Research

... -- The Robert C. Gallo Foundation for AIDS and virus Research today announced the appointment of ... is most widely known as co-discoverer of the HIV virus and developer of the first HIV blood test. ... About the Robert C. Gallo Foundation for AIDS and virus Research The Robert C. Gallo Foundation for ...

Vical Pandemic Influenza Vaccines Achieve T-Cell Responses and Cross-Clade Reactivity in Humans

... responses against a matching strain of influenza virus and demonstrated cross-clade antibody responses ... vaccine, which was based on the H5N1 influenza virus strain, A/Vietnam/1203/04, also induced antibody responses against the H5N1 influenza virus strain, A/Hong Kong/156/97 from a different ...

Roche, InterMune and Pharmasset Announce Initiation of INFORM-1, the First Dual-Combination Clinical Trial with Oral Antivirals in Hepatitis C

... chronically infected with the hepatitis C virus (HCV). The trial (run in centers in Australia and ... for the treatment of hepatitis B virus (HBV), hepatitis C virus (HCV) and human immunodeficiency virus (HIV). Pharmasset is currently developing three ...

U.S. Navy and U.S. Army to Develop Dengue DNA Vaccine Formulated With Vical's Vaxfectin(R) Adjuvant

... to Phase 1 human testing. About Dengue Dengue virus infects up to 100 million people each year. Its ... the Flavivirus family, which includes West Nile virus and yellow fever virus. Dengue virus is spread by mosquitoes, and is most common ...

Data Reported at ICAAC Indicates Selzentry(TM) Phase III Treatment-Naive Trial Shows Increased Efficacy When Used With Enhanced Trofile(TM) Assay

... or both coreceptors defines the "tropism" of the virus strain. Trofile amplifies the envelope gene from ... it to make HIV particles containing the patient's virus envelope protein. The resultant HIV particles are ... at identifying very low levels of CXCR4 using virus (X4 or dual/mixed tropic) in HIV-1 patient ...

Analysis of Long-Term Vicriviroc Data Provides Evidence of Sustained Viral Suppression, Increased CD4 Cell Counts and Tolerability in Treatment-Experienced HIV-Infected Patients

... of HIV infection designed to prevent the virus from infecting the immune system's CD4 cells by ... percent of treatment-experienced patients have virus that uses the CCR5 co-receptor.(1) Researchers ... within 12 weeks by a significant decrease in virus (HIV RNA) detectable in the blood and ...

Richard E.T. Smith, Ph.D. Joins Pharmasset as Vice President of Investor Relations and Corporate Communications

... world's population, are infected with hepatitis C virus (HCV). The CDC has reported that almost four ... for the treatment of hepatitis B virus (HBV), hepatitis C virus (HCV) and human immunodeficiency virus (HIV). Pharmasset is currently developing three ...

New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study

... weight gain). Reactivation of hepatitis B virus has been reported in patients who are carriers of this virus and are taking TNF blockers, such as REMICADE. ... know or think you may be a carrier of hepatitis B virus or if you experience signs of hepatitis B ...

Quigley Anti-Viral Compound QR448(a) Successfully Prevents Transmission of Infectious Bronchitis in Chickens

... prevent the transmission of Infectious Bronchitis virus (IBV) from infected to non-infected 2 week ... all infectious bronchitis viruses regardless of virus type. In addition, spray treatment of QR448(a) is ... available Arkansas type IBV vaccine virus and isolated for 2 hours. Due to safety, ...

Study Demonstrates That AHCC(R) Provides Immune Enhancement Against the West Nile Virus

... promising for individuals living with West Nile virus and populations susceptible such as the elderly ... in 1999, infections caused by the West Nile virus have become a major public health concern. West ... treatment for the disease. The West Nile virus study utilizing AHCC examined its effect in ...

Epiphany Biosciences to Continue Phase 2 Shingles Study After Interim Analysis; Plans Follow-On Clinical Trial Studying Post-Herpetic Neuralgia (PHN)

... and young adults, caused by Epstein-Barr virus (EBV), also a member of the herpes virus family. "Further studies of valomaciclovir ... spread of pathogenic viruses, including varicella virus (VZV), Epstein-Barr virus (EBV) and hepatitis ...

FDA Approves First Hepatitis B Viral Load Test

... first assay for quantitating Hepatitis B virus DNA approved in the U.S. The test uses Roche's ... technology to quantify the amount of Hepatitis B virus DNA in a patient's blood. Doctors may use viral ... goal of Hepatitis B therapy is to treat until the virus is undetectable in the patient's blood, it is ...

Positive Mosquito Count for West Nile Virus Lead DEP, Southeastern PA Counties to Ramp up Treatment Activities

... While only one human case of the West Nile virus has been confirmed this year (a 27-year-old ... the evening hours by state and county West Nile virus staff. Only those areas with mosquitoes that ... and Prevention, all residents in areas where virus activity has been identified are at risk ...

Pharmasset Reports Financial Results for Quarter Ended June 30, 2008

... for the treatment of chronic hepatitis B virus (HBV) infection, a $1.0 million increase in ... for the treatment of hepatitis B virus (HBV), hepatitis C virus (HCV) and human immunodeficiency virus (HIV). Pharmasset is currently developing three ...

Pharmasset Reports Preliminary Results of a 4-week Combination Study of R7128 for the Treatment of Chronic Hepatitis C

... patients chronically infected with hepatitis C virus (HCV) genotype 1. R7128, a prodrug of PSI-6130, ... world's population, are infected with hepatitis C virus (HCV). The CDC has reported that almost four ... for the treatment of hepatitis B virus (HBV), hepatitis C virus (HCV) and human ...

Start of Phase I Study for Intranasal Pandemic Influenza Vaccine deltaFLU

... the vaccine protection directly at the site of virus entry. 2. Effective Immune Response Though the vaccine looks like a pathogenic influenza virus to the body, it does not cause disease. However, ... immune response against a wide range of influenza virus variants, which is only conditionally ...

Pharmasset Announces Initiation of Combination Study of Clevudine and Viread(R) for HBV by French National Agency for Research on AIDS and Viral Hepatitis (ANRS)

... for the treatment of chronic hepatitis B virus (HBV) infection in non-cirrhotic patients. The ... for the treatment of hepatitis B virus (HBV), hepatitis C virus (HCV) and human immunodeficiency virus (HIV). Pharmasset is currently developing three ...